• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Life Science Market
Life Science News
Life Science Stocks
  • Life Science Market
  • Life Science News
  • Life Science Stocks

TEXT ME Study Reveals How Apps Can Help Manage Cardiovascular Disease

Morag Mcgreevey
Sep. 23, 2015 07:57AM PST
Life Science Investing

TEXT ME, a study using text messages to improve management of cardiovascular disease, offered examples of how mobile applications can be used to manage health conditions.

TEXT ME, a study using text messages to improve management of cardiovascular disease, offered examples of how mobile applications can be used to manage health conditions.
According to Med City News:

An editorial citing the study noted that the process for clinical validation could use some improvement and offered some recommendations.
For those unfamiliar with it, the TEXT ME randomized clinical trial (short for Tobacco, Exercise and Diet Messages) sent text messages with advice, motivation and information on diet, physical activity and smoking cessation to roughly half of the 710 participants with cardiovascular disease over a six-month period. The rest did not receive them. It then compared LDL levels, blood pressure and other relevant data. Those who received the text messages showed statistically significant, albeit modest, improvement compared with those who did not.
Drs. Zubin Eapen and Eric Peterson of Duke Clinical Research Institute, who wrote the editorial, liked the way the investigators worked with patients (as well as academics and clinicians) both in structuring the messages sent to participants. They were part of the collaboration process for developing the messages used in the study. The study also tracked patients’ use of text messages and satisfaction with them. Their insights could easily apply to the broader clinical validation programs underway at companies and institutions.

Click here to read the full article on Med City News.


 
life-science-investing
The Conversation (0)

Go Deeper

AI Powered
2025 Life Science Outlook: Australia Edition

2025 Life Science Outlook: Australia Edition

Cardiex Limited (ASX:CDX)

Cardiex Limited

Latest News

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

Lobe Sciences Reports First Quarter 2026 Results and Highlights

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Life Science Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES